Ignite Creation Date:
2025-12-24 @ 9:18 PM
Ignite Modification Date:
2025-12-25 @ 7:06 PM
Study NCT ID:
NCT01601704
Status:
TERMINATED
Last Update Posted:
2017-02-27
First Post:
2012-05-14
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
Sponsor:
Orexigen Therapeutics, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-06
Start Date Type:
None
Primary Completion Date:
2015-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-08
Completion Date Type:
ACTUAL
First Submit Date:
2012-05-14
First Submit QC Date:
None
Study First Post Date:
2012-05-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-12-11
Results First Submit QC Date:
None
Results First Post Date:
2017-02-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-24
Last Update Post Date:
2017-02-27
Last Update Post Date Type:
ACTUAL